Stifel Maintains Buy on Sientra, Lowers Price Target to $2
Sientra Analyst Ratings
Sientra's Market Challenges Yet Promising Portfolio Prompts Buy Rating: Vendetti's Analysis
Craig-Hallum Downgrades Sientra to Hold, Announces $2 Price Target
Sientra Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: ALX Oncology Holdings (ALXO), Atreca (BCEL) and Sientra (SIEN)
Analysts Offer Insights on Healthcare Companies: Sientra (SIEN) and ScPharmaceuticals (SCPH)
Craig-Hallum Reaffirms Their Buy Rating on Sientra (SIEN)
Craig-Hallum Keeps Their Buy Rating on Sientra (SIEN)
Sientra (SIEN) Gets a Buy From Maxim Group
Craig-Hallum Sticks to Its Buy Rating for Sientra (SIEN)
Craig-Hallum Adjusts Price Target on Sientra to $10 From $13, Maintains Buy Rating
Craig-Hallum Maintains Buy on Sientra, Lowers Price Target to $10
Analysts Offer Insights on Healthcare Companies: Sientra (SIEN) and Lineage Cell Therapeutics (LCTX)
Sientra Analyst Ratings
Lake Street Adjusts Sientra's Price Target to $2 From $8, Reiterates Buy Rating
Stifel Nicolaus Sticks to Its Buy Rating for Sientra (SIEN)
Sientra (SIEN) Receives a Buy from Maxim Group
Stifel Nicolaus Adjusts Sientra Price Target to $4 From $7, Maintains Buy Rating